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Antibody against Myelin-Associated Inhibitor
of Neurite Growth Neutralizes Nonpermissive
Substrate Properties of CNS White Matter
Pico Caroni* and Martin E. Schwab*
*Brain Research Institute, University of Zurich, August-Forel-Strasse 1, CH-8029 Zurich, Switzerland
CNSwhitematter from higher vertebrates and cultured differentiated oligodendrocytes are nonpermissive
substrates for neurite growth and fibroblast spreading. Membrane proteins of 35 kd and 250 kdwith highly
nonpermissive substrate properties could be extracted fromCNSmyelin fractions.Monoclonal antibodies
were raised against these proteins: IN-1 and IN-2 bound both to the 35 kd and 250 kd inhibitors and
to the surface of differentiated cultured oligodendrocytes. Adsorption of nonpermissive CNS myelin or
nonpermissive oligodendrocytes with either antibody markedly improved their substrate properties.
Optic nerve explants injected with IN-1 or IN-2 allowed axon ingrowth of cocultured sensory and
sympathetic neurons. We conclude that the nonpermissive substrate properties of CNS white matter
are due to these membrane proteins on the surface of differentiated oligodendrocytes and to their
in vivo product, myelin.
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ReflectionsAt the time of our 1988 paper, data from microscopy done ex-
clusively on fixed, dead tissue had lead to a picture of the adult
CNS as a highly complex but essentially static network structure.
In light of the complexity of CNSwiring, clinical and experimental
observations also supported the notion that there was a general
absence of long-distance (more than 0.5 to a few millimeters)
fiber growth or regeneration after CNS lesions. The paper pub-
lished by us in the first issue of Neuron showed that the adult
CNS tissue actively prevents long-distance growth of neurites,
mainly due to components of CNS myelin, in particular a high
molecular weight component called NI-250, later renamed
Nogo-A.Neutralizing antisera andmonoclonal antibodiesagainst
this protein were shown to enhance neurite outgrowth on CNS
myelin substrates and ingrowth of neurites into adult rat optic
nerve explants over many millimeters. These findings were not
easily accepted—why should there be growth inhibitory factors
in the adult CNS, and why in myelin? The repellent and inhibitory
guidance cues in the developing nervous system were not yet
known. Indeed, they appeared on the horizon of neuroscience
simultaneously with the CNS myelin inhibitory factors and
Nogo-A. The lab of Friedrich Bonhoeffer showed that proteins
of posterior tectal membranes of the chicken embryo specifically
repel growing axons from the temporal retina; these findings
gave rise to the identification of Ephrins as axonal guidance fac-
tors. Simultaneously, Jonathan Raper started to characterize a
neurite-derived growth cone collapsing factor that later became
Semaphorin 3A. A fewmonths later, in the fourth issue of the first
volume of Neuron, an influential review by Paul H. Patterson
summarized these findings under the title of ‘‘On the importance
of being inhibited, or saying no to growth cones.’’ This new con-
cept of a balanced interplay of attractive and growth promoting
factors on the one hand and repulsive or growth inhibitory factors404 Neuron 60, November 6, 2008 ª2008 Elsevier Inc.on the other hand made a lot of sense for the understanding of
developmental processes. The concept was extremely fruitful
and produced our current picture of targeted neurite growth and
guidance.
Going forward, possible functions for the potent neurite growth
inhibitory action of CNS myelin-associated proteins and espe-
cially Nogo-A in the adult CNS were more difficult to find. One
of the monoclonal function-blocking antibodies described in the
1988 Neuron paper was used to test the hypothesis of a key
involvement of these factors in the restricted regeneration of
injured axons in vivo. In a brute force approach, we implanted
antibody-secreting hybridoma cells into the brains of spinal cord
injured rats and found to our great surprise that the short sprouts
produced spontaneously by the axotomized corticospinal axons
elongated over many millimeters into the spinal cord, caudal to
the injury. The resultswere very similar to those obtained in simul-
taneous experiments in rats in which oligodendrocytes were
ablated andmyelinationwas prevented in the lumbar spinal cord.
Nogo-A being a high molecular weight membrane protein with
relatively lowabundance, it took 10 years to fully purify theprotein
and obtain partial sequences. These sequences then allowed
cloning of the cDNA in the year 2000. A variety of reagents,
including new anti-Nogo antibodies and reagents interfering
with Nogo receptor components and the signaling pathways,
confirmed the original findings of enhanced axonal regeneration
after spinal cord or brain injuries but also showed the occurrence
of enhanced compensatory growth of intact fibers, associated
with often impressive degrees of functional recovery. The appli-
cation of function-blocking anti-Nogo antibodies in paraplegic
patients is currently being studied in an ongoing clinical trial.
The physiological role of growth inhibitory factors in the normal
adult CNS remains a key open question. Correlative evidence
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Reflectionssuggests that they function as controllers of the CNS, which in
the 20 years between 1988 and now, has been recognized to
be everything else other than a static structure: a highly plastic,
continuously changing and growing network. Up to 1997, the
evidence for structural plasticity in the adult had been indirect
and mainly based on quantitative electron microscopy or Golgi
preparations in animals that had undergone learning or stress
protocols. Conclusive direct evidence came with the advent of
genetic methods to fluorescently label individual neurons or their
subcellular compartments, in combination with repeated two-
photon imaging of those labeled neurons in living animals. The
in vivo studies revealed the existence of distinct subpopulations
of plastic synapses, which turn over with half-lives of days and
weeks in the adult. Consistent with the expectation that this
structural plasticity should be influenced by experience, T. Bon-
hoeffer and D. Muller provided evidence that long-term potenti-
ation of synaptic transmission is accompanied by the formation
of new spine synapses. In a further blow to the notion that sub-
stantial circuit plasticity is restricted to development, L. Maffei,
M.P. Stryker, and T. Hentsch provided evidence that so-called
critical periods are not all-or-none transitions to stable circuits
in the adult, but that periods of enhanced plasticity can be
extended into adulthood or even be reactivated in the adult.
In a development of major potential significance for clinical ap-
plications, structural plasticity, learning, and repair could be
enhanced through training. Given this emerging view of a struc-
turally plastic CNS in the adult, it is worth reconsidering the pos-sible roles of inhibitory regulators such as Nogo-A. One question
is whether the inhibitors are specifically involved in controlling
nerve sprouting orwhether theymight be involved in a continuum
of structural plasticity responses, from synapse remodeling to
local and large-scale nerve sprouting and synaptogenesis. Fur-
thermore, Nogo receptor activation also appears to affect gene
expression programs in neurons, to influence their responses to
plasticity-inducing signals. Whether the functional impact of
such gene expression responses is felt throughout a neuron’s
processes and synapses or is further modified through local
regulation remains to be determined.
Paradoxically, the discovery of neurite growth inhibitors in the
adult CNS has directed our attention to the exquisite structural
plasticity of the adult CNS. Contrary to initial concerns, and likely
due to robust mechanisms relating structural plasticity to func-
tion, the induced plasticity has mainly turned out to be beneficial
and restorative. The race is therefore on to find ever more effec-
tive and specific ways to enhance plasticity in the adult in order
to harness its potential for brain repair.
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